LSV Asset Management Has $7.66 Million Stock Holdings in GoodRx Holdings, Inc. $GDRX

LSV Asset Management increased its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) by 20.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,825,900 shares of the company’s stock after acquiring an additional 471,319 shares during the quarter. LSV Asset Management owned about 0.83% of GoodRx worth $7,658,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Lazard Asset Management LLC increased its holdings in shares of GoodRx by 43.6% in the second quarter. Lazard Asset Management LLC now owns 17,142 shares of the company’s stock worth $85,000 after acquiring an additional 5,201 shares in the last quarter. Brevan Howard Capital Management LP increased its holdings in shares of GoodRx by 7.7% in the third quarter. Brevan Howard Capital Management LP now owns 95,483 shares of the company’s stock worth $404,000 after acquiring an additional 6,842 shares in the last quarter. Hirtle Callaghan & Co LLC increased its holdings in shares of GoodRx by 60.3% in the fourth quarter. Hirtle Callaghan & Co LLC now owns 18,261 shares of the company’s stock worth $49,000 after acquiring an additional 6,869 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of GoodRx by 202.3% in the second quarter. Tower Research Capital LLC TRC now owns 11,327 shares of the company’s stock worth $56,000 after acquiring an additional 7,580 shares in the last quarter. Finally, Quarry LP bought a new stake in shares of GoodRx in the third quarter worth about $33,000. Institutional investors and hedge funds own 63.77% of the company’s stock.

GoodRx Stock Up 4.9%

NASDAQ:GDRX opened at $2.78 on Wednesday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.47 and a current ratio of 1.47. The company has a market cap of $952.34 million, a PE ratio of 46.34, a PEG ratio of 1.69 and a beta of 1.54. GoodRx Holdings, Inc. has a 52-week low of $1.77 and a 52-week high of $5.81. The stock has a 50-day simple moving average of $2.32 and a 200 day simple moving average of $2.49.

GoodRx (NASDAQ:GDRX) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.07. The firm had revenue of $194.01 million during the quarter, compared to the consensus estimate of $185.40 million. GoodRx had a return on equity of 7.90% and a net margin of 2.61%.The business’s revenue was down 4.4% compared to the same quarter last year. During the same period last year, the company earned $0.09 earnings per share. On average, sell-side analysts expect that GoodRx Holdings, Inc. will post 0.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on GDRX shares. Citigroup increased their price target on GoodRx from $3.50 to $4.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of GoodRx in a report on Friday, February 27th. The Goldman Sachs Group reiterated a “neutral” rating and set a $3.50 price objective on shares of GoodRx in a report on Friday, May 8th. Wells Fargo & Company decreased their price objective on GoodRx from $7.00 to $3.50 and set an “overweight” rating for the company in a report on Wednesday, March 4th. Finally, Leerink Partners reiterated an “outperform” rating and set a $3.00 price objective on shares of GoodRx in a report on Thursday, February 26th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $3.81.

GoodRx Company Profile

GoodRx Holdings, Inc (NASDAQ: GDRX) operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications. The platform also features price transparency tools that inform patients about cost variations and available discounts to alleviate the financial burden of prescription medications.

In addition to its core drug pricing service, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual consultations for a range of non-emergency conditions and prescription needs.